Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year book value per share growth
Latest
-1.67%
↓ 154% vs avg
Percentile
P33
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-0.66%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -1.67% |
| Q3 2025 | -0.79% |
| Q2 2025 | -0.72% |
| Q1 2025 | -1.74% |
| Q4 2024 | -13.26% |
| Q3 2024 | -14.08% |
| Q2 2024 | -0.09% |
| Q1 2024 | -2.10% |
| Q4 2023 | -21.59% |
| Q3 2023 | -0.93% |
| Q2 2023 | -2.03% |
| Q1 2023 | -2.38% |
| Q4 2022 | -1.45% |
| Q3 2022 | -1.68% |
| Q2 2022 | 1.90% |
| Q1 2022 | -1.15% |
| Q4 2021 | -0.59% |
| Q3 2021 | 0.88% |
| Q2 2021 | 3.31% |
| Q1 2021 | 1.08% |
| Q4 2020 | -4.71% |
| Q3 2020 | -1.43% |
| Q2 2020 | -1.77% |
| Q1 2020 | 2.40% |
| Q4 2019 | 0.87% |
| Q3 2019 | 11.02% |
| Q2 2019 | -4.93% |
| Q1 2019 | 1.95% |
| Q4 2018 | 3.77% |
| Q3 2018 | 6.53% |
| Q2 2018 | -7.25% |
| Q1 2018 | 0.53% |
| Q4 2017 | 3.91% |
| Q3 2017 | 3.81% |
| Q2 2017 | 6.05% |
| Q1 2017 | 2.99% |
| Q4 2016 | 4.46% |
| Q3 2016 | 5.34% |
| Q2 2016 | 6.03% |
| Q1 2016 | -6.78% |